SLC5A2 and Hypertension: In obese patients affected by arterial hypertension, adding a GLP1-RA and an SGLT2-i on top of a RAAS antagonist and the often-needed diuretic can provide effective metabolic, CV, and renal protection, especially in the presence of subclinical or clinical target organ damage.